P-8
Preclinical Cardiac Involvement In Progressive
External Ophthalmoplegia by Franzoni, F. et al.
164
10th Congress of The Mediterranean Society of Myology, April 28-30, 2011
P-8
Preclinical Cardiac Involvement In Progressive 
External Ophthalmoplegia
F. Franzoni, F. Galetta, D. Orsucci, M. Mancuso, G. Ricci, 
L. Tocchini, E. Guidotti, R. Papi, G. Siciliano, G. Santoro
Department of Internal Medicine and Department of Neurosciences, 
University of Pisa, Italy
Aim of this study was to evaluate in patients with progres-
sive external ophthalmoplegia (PEO) the left ventricular func-
tion by standard echocardiography and tissue Doppler imaging 
(TDI) analysis. Twenty patients with PEO (55.4 ± 17.5 years) 
and 20 age- and sex-matched healthy subjects underwent stand-
ard echocardiography with TDI analysis to assess left ventricu-
lar function. TDI was performed by placing the sample volume 
in the center of the basal lateral segment and the basal inter-
ventricular septum in the apical 4-chamber view. Myocardial 
systolic wave (Sm) and early (Em) and atrial (Am) diastolic waves 
were measured.
On standard echocardiography examination, no significant 
changes in left ventricular systolic function parameters were 
observed. Instead, the indices of left ventricular diastolic func-
tion were significantly lower in PEO patients respect to controls 
(peak E, 75.4 ± 11.2 vs. 58.8 ± 12.5 cm/sec, p < 0.01; E/A ratio, 
1.0 ± 0.3 vs. 0.8 ± 0.2, p < 0.01). Regarding TDI measures, the 
PEO patients exhibited as compared to control subjects a lower 
Sm peak (septum: 7.6 ± 1.1 vs. 9.9 ± 0.8 cm/sec; lateral wall: 
9.7 ± 1.7 vs. 12.8 ± 1.2 cm/sec, p < 0.001), a lower Em peak (sep-
tum: 9.3 ± 1.6 vs. 12.8 ± 1.7 cm/sec; lateral wall: 10.2 ± 2.4 vs. 
14.1 ± 1.9 cm/sec, p < 0.001), and a reduced Em/Am ratio (sep-
tum: 1.0 ± 0.4 vs. 0.7 ± 0.2; lateral wall: 1.2 ± 0.5 vs. 0.7 ± 0.2, 
p < 0.001, respectively).
Our  data  indicate  that  although  cardiac  involvement  in 
patients with PEO is generally considered to be limited to the 
cardiac conduction system, left ventricular dysfunction may be 
present and should receive more attention in the management 
of patients with PEO. Pulsed TDI offers an additional means 
to conventional echocardiography for assessing left ventricular 
diastolic function and to identify preclinical systolic myocardial 
involvement in PEO patients.
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In recent years, a flurry of epidemiological studies has con-
firmed the notion that mitochondrial disorders (MD) are among 
the most common genetic disorders and a major burden for so-
ciety. However, in contrast to the extraordinary progress in our 
understanding of the biochemical and molecular bases of MD, 
we are still extremely limited in our ability to treat these con-
ditions. Small patient populations represent the major impedi-
ment to progress in research and care. The development, by a 
multicenter nationwide collaborative network, of a web-based 
register of patients with MD will be helpful to better understand 
the phenotypes and the natural history of these diseases.
The  GUP09004  Telethon-Clinical  Grant  project  started 
on January 2010. Eleven Centers with expertise on MD have 
been involved. The initial phases (“establishment of the steering 
committee and the oversee committee” and “development and 
validation of the register”) are completed and, having discussed 
some ethical, procedural and statistical issues, a data matrix has 
been defined including the more relevant clinical and laboratory 
parameters, such as: patient code, family code, date of birth, 
gender, region of origin, ethnicity, family history, diagnosis, 
year of diagnosis, age at onset, form, first symptoms, clinical 
features, clinical course, date and cause of death, Newcastle 
Scale scores, date of the last contact, plasmatic/urinary/CSF 
biomarkers,  neuro-ophtalmological  features,  neuroradiologic 
features, proton magnetic resonance spectroscopy, histological 
findings, respiratory chain complexes complexes, pyruvate de-
hydrogenase, molecular analysis (southern blotting, long PCR, 
real time PCR, nuclear DNA genotype, mtDNA genotype with 
haplogroups) and therapy. By using a digitalized version of this 
matrix 145 patients from the 11 participating Centers have been 
charged on the database.
The ongoing phase provides a validation step of the data-
base build-up by reassessment of all the cases in each Center, 
preliminary to the web-database where the obtained data will be 
transferred for an estimated population of nearly 3000 patients.
Possible  future  applications,  based  on  such  nation-wide 
Italian  collaborative  network,  will  include:  epidemiological 
studies, phenotype-genotype correlations, disease natural his-
tory definition, multicenter clinical trials.